Asia Pacific Wearable Injectors Market Size & Outlook
Asia Pacific wearable injectors market, 2018-2030 (US$M)
Related Markets
Asia Pacific wearable injectors market highlights
- The Asia Pacific wearable injectors market generated a revenue of USD 1,645.8 million in 2023.
- The market is expected to grow at a CAGR of 15.6% from 2024 to 2030.
- In terms of segment, on-body was the largest revenue generating type in 2023.
- Off-body is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Thailand is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,645.8 million |
| Market revenue in 2030 | USD 4,545.9 million |
| Growth rate | 15.6% (CAGR from 2023 to 2030) |
| Largest segment | On-body |
| Fastest growing segment | Off-body |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | On-body, Off-body |
| Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.7% of the global wearable injectors market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,545.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Wearable Injectors Market Scope
Wearable Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific wearable injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 54.34% in 2023. Horizon Databook has segmented the Asia Pacific wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific region is majorly driven by China and Japan. China dominated the overall wearable injectors market in terms of revenue share. This can be attributed to the local presence of major market players and increasing prevalence of chronic disorders. China is anticipated to be the fastest-growing market during the forecast period in the region.
Thailand, Australia, and South Korea are some of the emerging countries in the rest of this region. Technological advancements in wearable injectors and the increasing geriatric population, coupled with the growing prevalence of lifestyle diseases such as obesity & diabetes, are anticipated to drive growth of wearable injectors market.
Cardiovascular diseases are among the leading causes of increased mortality and morbidity in Asia Pacific. According to the Australian Institute of Health and Welfare (AIHW), approximately 2.9% of Australian adults aged 18 and over had one or more conditions related to vascular or heart disease, including stroke, from 2020 to 2021.
Reasons to subscribe to Asia Pacific wearable injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific wearable injectors market databook
-
Our clientele includes a mix of wearable injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific wearable injectors market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific wearable injectors market size, by country, 2018-2030 (US$M)
Asia Pacific Wearable Injectors Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
